Incyte Can't Get Pretrial Win In Novartis Royalty Fight
By Adam Lidgett · April 7, 2025, 7:13 PM EDT
A New York federal judge has disagreed with Incyte Corp.'s argument that its interpretation of a drug commercialization contract at the heart of a royalties dispute with Novartis Pharma AG is the...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login